Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 520.87% | 251.15% | 0.67% | -79.19% | -80.39% |
| Total Other Revenue | 21.07% | 25.60% | 20.10% | 33.22% | 45.52% |
| Total Revenue | 48.35% | 39.35% | 16.67% | 1.00% | 7.75% |
| Cost of Revenue | 26.19% | 35.75% | 9.92% | -14.74% | -21.12% |
| Gross Profit | 63.20% | 41.73% | 21.57% | 15.01% | 42.73% |
| SG&A Expenses | 24.79% | 35.20% | 17.70% | 8.81% | 3.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.01% | 29.24% | 11.61% | 0.60% | -1.19% |
| Operating Income | -15.40% | -26.74% | -10.38% | -0.50% | 3.21% |
| Income Before Tax | 2.22% | -7.82% | 2.83% | -3.82% | -0.24% |
| Income Tax Expenses | 98.44% | -97.72% | -147.06% | -145.07% | -144.60% |
| Earnings from Continuing Operations | 1.79% | -6.71% | 4.45% | -2.15% | 1.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.79% | -6.71% | 4.45% | -2.15% | 1.21% |
| EBIT | -15.40% | -26.74% | -10.38% | -0.50% | 3.21% |
| EBITDA | -15.89% | -27.77% | -10.94% | -1.37% | 1.94% |
| EPS Basic | 15.69% | 4.48% | 11.75% | 2.59% | 2.90% |
| Normalized Basic EPS | 16.10% | -5.94% | 1.35% | -9.29% | -8.10% |
| EPS Diluted | 15.87% | 4.27% | 11.54% | 2.37% | 2.69% |
| Normalized Diluted EPS | 16.10% | -5.94% | 1.35% | -9.29% | -8.10% |
| Average Basic Shares Outstanding | 16.89% | 12.35% | 9.02% | 5.58% | 1.72% |
| Average Diluted Shares Outstanding | 16.89% | 12.35% | 9.02% | 5.58% | 1.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |